Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Proteome Res ; 23(7): 2376-2385, 2024 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-38856018

RESUMO

Schizophrenia is a severe psychological disorder. The current diagnosis mainly relies on clinical symptoms and lacks laboratory evidence, which makes it very difficult to make an accurate diagnosis especially at an early stage. Plasma protein profiles of schizophrenia patients were obtained and compared with healthy controls using 4D-DIA proteomics technology. Furthermore, 79 DEPs were identified between schizophrenia and healthy controls. GO functional analysis indicated that DEPs were predominantly associated with responses to toxic substances and platelet aggregation, suggesting the presence of metabolic and immune dysregulation in patients with schizophrenia. KEGG pathway enrichment analysis revealed that DEPs were primarily enriched in the chemokine signaling pathway and cytokine receptor interactions. A diagnostic model was ultimately established, comprising three proteins, namely, PFN1, GAPDH and ACTBL2. This model demonstrated an AUC value of 0.972, indicating its effectiveness in accurately identifying schizophrenia. PFN1, GAPDH and ACTBL2 exhibit potential as biomarkers for the early detection of schizophrenia. The findings of our studies provide novel insights into the laboratory-based diagnosis of schizophrenia.


Assuntos
Biomarcadores , Profilinas , Proteômica , Esquizofrenia , Esquizofrenia/metabolismo , Esquizofrenia/diagnóstico , Esquizofrenia/sangue , Humanos , Biomarcadores/sangue , Biomarcadores/metabolismo , Proteômica/métodos , Profilinas/metabolismo , Feminino , Masculino , Adulto , Estudos de Casos e Controles , Gliceraldeído-3-Fosfato Desidrogenase (Fosforiladora)/metabolismo , Pessoa de Meia-Idade , Proteínas Sanguíneas/análise , Proteoma/análise
2.
Zhongguo Zhong Yao Za Zhi ; 40(10): 1860-4, 2015 May.
Artigo em Chinês | MEDLINE | ID: mdl-26390638

RESUMO

OBJECTIVE: To establish the quality standard of Entadae Semen, and provide scientific basis for its quality control. METHOD: TLC and HPLC were used for qualitative identification and quantitative analysis of phaseoloidin and entadamide A-O-ß-D-glucopyranoside in Entadae Semen. The test of water content, ash and ethanol-soluble extractives of Entadae Semen was carried out according to the methods recorded in appendix of Chinese Pharmacopeia (2010 edition). RESULT: The TLC was well separated with clear spots. The linear range of phaseoloidin was between 0.014 to 2.747 g x L(-1) (r = 0.999 6, n = 9) with an average recovery rate of 101.06% (RSD 0.90%, n = 6); the linear range of entadamide A-O-ß-D-glucopyranoside was between 0.002 to 0.452 g x L(-1) (r = 0.999 7, n = 9) withan average recovery rate of 101.52% (RSD 1.09%, n = 6). The content of phaseoloidin in sample is between 5.12% to 9.24%, entadamide A-O-ß-D-glucopyranoside is between 0.55% to 2.17%, alcohol-soluble extracts is between 30.9% to 45.2%, water is between 6.6% to 8.6%, and total ash is between 2.4% to 2.9%. CONCLUSION: The established standard is acceptable for quality control of Entadae Semen.


Assuntos
Medicamentos de Ervas Chinesas/química , Fabaceae/química , China , Cromatografia Líquida de Alta Pressão , Cromatografia em Camada Fina , Medicamentos de Ervas Chinesas/isolamento & purificação , Medicamentos de Ervas Chinesas/normas , Controle de Qualidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...